Cook Regentec, Indianapolis, and Asymptote Ltd, Cambridge, UK, have launched the CellSeal automated thawing system. The system provides users with thorough control in the thawing of cryogenically frozen cells, and works through dry conduction without requiring water, a potential source of contamination. Users can tune a thaw profile to suit the specific needs of their cellular therapy, then lock the profile down for one-touch repeatability. The system removes user subjectivity by detecting the precise thaw end-point. Data recording captures a record of the thaw process. The scalable system supports good manufacturing practice requirements. For more information, visit Cook Regentec and Asymptote Ltd.
September 5, 2017